Showing results (31-40 of 624) with videos related to
Sort By:
Pageof 63
Blood|November 1, 1992
Use of recombinant human granulocyte-macrophage colony-stimulating factor in patients with lymphoid malignancies transplanted with unpurged or adjusted-dose mafosfamide-purged autologous marrowC Carlo-Stella, L Mangoni, C Almici, et al.Haematologica|January 1, 1989
Results of two different conditioning regimens followed by ABMT in refractory acute lymphoblastic leukemiaG Meloni, P De Fabritiis, A Pulsoni, et al.Bone Marrow Transplantation|January 1, 1990
Autologous bone marrow transplantation in patients with AML in first complete remission. Results of two different conditioning regimens after the same induction and consolidation therapyG Meloni, P De Fabritiis, A M Carella, et al.Leukemia Research|January 1, 1982
Vindesine in the treatment of refractory hematologic malignancies: a phase II studyF Mandelli, S Amadori, F Giona, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 1, 1997
Etoposide, intermediate-dose cytarabine and carboplatin (VAC): a combination therapy for the blastic phase of chronic myelogenous leukemiaE Montefusco, M C Petti, G Alimena, et al.Case Reports in Hematology|September 10, 2020
A Rare Case of Coexisting Breast Cancer and Refractory Acute Myeloid LeukemiaL Ballotta, S M Trisolini, A P Iori, et al.Leukemia|April 1, 1994
Adult Philadelphia-chromosome-positive acute lymphoblastic leukemia: experience of treatments during a ten-year periodL Annino, A Ferrari, M Cedrone, et al.Blood|October 1, 1994
Interleukin-2 may induce prolonged remissions in advanced acute myelogenous leukemiaG Meloni, R Foa, M Vignetti, et al.Journal of Endocrinological Investigation|October 1, 1989
Immunoreactive beta-endorphin levels in cerebrospinal fluid of children with acute lymphoblastic leukemia: relationship with glucocorticoid therapy and neurological complicationsP Iannetti, A Fabbri, G Meloni, et al.Cancer|October 1, 1987
Late multifocal gliomas in adolescents previously treated for acute lymphoblastic leukemiaM Fontana, C Stanton, A Pompili, et al.Pageof 63